CC vs FUL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CC · The Chemours$10.88 ▼ 7.80%
FUL · H.B. Fuller$46.24 ▼ 2.80%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CC +10.1%
- FUL -12.6%
Head to head
| Metric | CC | FUL |
|---|---|---|
| Price | $10.88 | $46.24 |
| Change today | ▼ 7.80% | ▼ 2.80% |
| Market cap | $1.64B | $2.49B |
| Return, 3 months | -29.4% | -20.3% |
| Return, year to date | -6.4% | -21.3% |
| Return, 1 year | -1.9% | -18.4% |
| P/E (TTM) | – | 12.9 |
| P/B | 10.6 | 1.1 |
| P/E percentile vs own 5y | 14th | 0th |
| Dividend yield | 3.22% | 2.08% |
| Revenue growth (YoY, latest qtr) | +3.0% | +5.2% |
| Net profit growth (YoY) | +326.1% | +17.8% |
| Gross margin | 15.1% | 32.3% |
| Operating margin | 0.8% | 11.3% |
| Net margin | -2.6% | 5.6% |
| Return on equity | -68.0% | 9.6% |
| Analyst target vs. price | +55.2% | +34.5% |
| Analyst buy share | 33% | 80% |
| RSI (14) | 40 | 33 |
| 30-day volatility | 43.2% | 32.0% |
| Max drawdown, 1 year | -54.9% | -30.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- FUL is the largest of the group by market value.
- CC has returned the most over the past year.
- CC pays the highest dividend yield.
- FUL is growing revenue fastest.
- FUL keeps the most profit per dollar of sales.
- FUL has been the calmest stock over the last 30 days.